Basit öğe kaydını göster

5-HT and Dopamine Antagonists, Their Favors and Harms

dc.contributor.authorDoksat, Mehmet Kerem
dc.date.accessioned2021-03-03T12:11:38Z
dc.date.available2021-03-03T12:11:38Z
dc.identifier.citationDoksat M. K. , "5-HT and Dopamine Antagonists, Their Favors and Harms", KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.19, 2009
dc.identifier.issn1017-7833
dc.identifier.othervv_1032021
dc.identifier.otherav_2c7463b0-2f31-474f-80aa-b279e4800aa2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/34583
dc.description.abstractSome drugs called new generation, second generation and atypical antipsychotics invaded everywhere during the last ten to fifteen years. Initial publication was amazing: without any side effects, they would get rid of schizophrenia, psychosis, and even bipolarity. Astute and skeptical scientists were cautious and observing. Finally it was understood that they had all the unwanted side-effects of the classical neuroleptics, including the fatal ones: extrapyramidal, endocrine-metabolic, and others...
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectPsikiyatri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.title5-HT and Dopamine Antagonists, Their Favors and Harms
dc.typeMakale
dc.relation.journalKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume19
dc.contributor.firstauthorID191509


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster